Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 32 - Rémy Evard on Organizing Trials, Declining Resources, and AI Development
Trends from the Trenches
25 minutes
1 year ago
Episode: 32 - Rémy Evard on Organizing Trials, Declining Resources, and AI Development
In this episode of Trends from the Trenches, host Stan Gloss discusses high-performance computing and its progress over the years with Rémy Evard, chief digital officer and head of technology at Memorial Sloan Kettering Cancer Center (MSK). They delve into the impact of cloud technology, the rapid development of AI (and the overexcitement around it), and the current industry-wide issue of maintaining healthcare quality during a time of declining resources. Evard also shares the responsibiliti...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
